Tinnitus Treatment Guidelines
Classification and Diagnosis
- The American College of Radiology suggests that subjective tinnitus is the most common form, while objective tinnitus is rare and may indicate an underlying vascular abnormality 1
- The American College of Radiology recommends classification of tinnitus into pulsatile or non-pulsatile, and primary or secondary, to guide treatment 1
- A comprehensive otologic examination is essential to identify potential vascular retrotympanic masses, as recommended by the American College of Radiology and Praxis Medical Insights 1, 2
Evidence-Based Treatment Options
- The American College of Cardiology is not mentioned, however, Praxis Medical Insights recommends Cognitive Behavioral Therapy (CBT) as the strongest evidence-based treatment for improving quality of life in patients with persistent, bothersome tinnitus 3
- Praxis Medical Insights suggests that hearing aids are recommended for patients with hearing loss and tinnitus, even if hearing loss is mild or unilateral 3
- Education and counseling are essential components for all patients with persistent tinnitus, as recommended by Praxis Medical Insights 3
Special Considerations
- Praxis Medical Insights notes that pulsatile tinnitus almost always requires imaging evaluation, unlike bilateral non-pulsatile tinnitus 2
- The Journal of the American College of Radiology recommends prompt identification and intervention for patients with severe anxiety or depression due to increased suicide risk in tinnitus patients with psychiatric comorbidities 1
Treatment Algorithm
- The American College of Radiology and Praxis Medical Insights recommend determining tinnitus characteristics, including pulsatile or unilateral, to guide imaging studies and identify treatable causes 1, 2
- Praxis Medical Insights suggests addressing any underlying treatable conditions, and using CBT, education, and counseling for persistent, bothersome tinnitus 3, 1, 2
Tinnitus Treatment Guidelines
First-Line Treatment Approaches
- The American Academy of Otolaryngology-Head and Neck Surgery recommends hearing aids for patients with hearing loss and tinnitus, even if the hearing loss is only mild or unilateral 4, 5
- Sound therapy may be recommended as a management option for persistent tinnitus, providing symptomatic relief 4, 5
Treatments Not Recommended
- The American Academy of Otolaryngology-Head and Neck Surgery does not recommend antidepressants, anticonvulsants, anxiolytics, or intratympanic medications for primary treatment of persistent tinnitus due to insufficient evidence and potential side effects 4, 5
- Dietary supplements, including Ginkgo biloba, melatonin, zinc, or other supplements, should not be recommended due to lack of consistent benefit 4, 5
Treatment Algorithm
Treatment Efficacy
- Cognitive Behavioral Therapy (CBT) has the strongest evidence for improving quality of life in tinnitus patients 4, 5
- Hearing aids can provide significant relief for patients with associated hearing loss 4, 5
Common Pitfalls to Avoid
- Prescribing medications without clear evidence of benefit that may cause side effects or worsen tinnitus should be avoided 4, 5
- Recommending dietary supplements that lack evidence of efficacy should be avoided 4, 5
- Overlooking mild hearing loss that could benefit from hearing aid intervention should be avoided 4, 5
Tinnitus Management Guidelines
Initial Evaluation and Classification
- The American Academy of Otolaryngology-Head and Neck Surgery recommends performing a targeted history and physical examination to identify potentially treatable underlying conditions that may cause tinnitus in patients with recent onset or persistent tinnitus 6
- The American Academy of Otolaryngology-Head and Neck Surgery suggests distinguishing between bothersome and non-bothersome tinnitus, as this classification guides treatment decisions for patients with tinnitus 7
- The American Academy of Otolaryngology-Head and Neck Surgery recommends obtaining a comprehensive audiologic examination for patients with tinnitus that is unilateral, persistent (≥6 months), or associated with hearing difficulties 7
- The American Academy of Otolaryngology-Head and Neck Surgery advises against obtaining imaging studies for tinnitus evaluation unless one or more of the following are present: unilateral tinnitus, pulsatile tinnitus, focal neurological abnormalities, or asymmetric hearing loss 7, 8
Evidence-Based Management Options
- The American Academy of Otolaryngology-Head and Neck Surgery recommends providing education and counseling about tinnitus management strategies for patients with persistent, bothersome tinnitus 7
- The American Academy of Otolaryngology-Head and Neck Surgery suggests recommending a hearing aid evaluation for patients with hearing loss and persistent, bothersome tinnitus, even if hearing loss is mild or unilateral 7
- The American Academy of Otolaryngology-Head and Neck Surgery recommends cognitive behavioral therapy (CBT) for patients with persistent, bothersome tinnitus 7
- The American Academy of Otolaryngology-Head and Neck Surgery advises against routinely recommending antidepressants, anticonvulsants, anxiolytics, or intratympanic medications for treating persistent, bothersome tinnitus 7
- The American Academy of Otolaryngology-Head and Neck Surgery recommends against dietary supplements such as Ginkgo biloba, melatonin, zinc, or other supplements for tinnitus management due to lack of evidence 7
Special Considerations
- The American College of Radiology suggests considering vascular causes and obtaining appropriate imaging (CTA or MRA) to identify potentially treatable conditions for patients with pulsatile tinnitus 8
- The American College of Radiology recommends prompt identification and intervention for patients with tinnitus and severe anxiety or depression due to increased suicide risk 8
Tinnitus Treatment Guidelines
Chemotherapy-Induced Tinnitus
- For patients with tinnitus secondary to platinum-based chemotherapy, no causative treatment exists for established ototoxicity, according to the American Society of Clinical Oncology 9
- Hearing aids remain beneficial for patients with chemotherapy-induced tinnitus, as recommended by the American Academy of Audiology 9
- CBT strategies can be offered for chemotherapy-induced tinnitus, with moderate evidence supporting its effectiveness, as suggested by the National Comprehensive Cancer Network 9
- Sodium thiosulfate may be considered for prevention in children receiving cisplatin, but its use in adults is uncertain due to concerns about tumor protection, as noted by the American Society of Clinical Oncology 9
Tinnitus Management Guideline
Introduction to Tinnitus Treatment
- The American Academy of Otolaryngology-Head and Neck Surgery recommends managing tinnitus occurring as part of Ménière's disease by controlling the underlying vestibular disorder rather than tinnitus specifically 10, 11, 12
Special Populations
- For patients with medication-induced tinnitus, such as those receiving cisplatin, hearing aids and cognitive behavioral therapy remain beneficial for managing symptoms, although no treatment can reverse established ototoxicity 10, 11, 12
- Sodium thiosulfate may prevent ototoxicity in children receiving cisplatin, but its use in adults is uncertain 10, 11, 12
Tinnitus Management in Patients with Comorbid Conditions
Diagnosis and Treatment Approach
- The American Academy of Otolaryngology-Head and Neck Surgery recommends a team approach involving otolaryngology, audiology, and mental health professionals for optimal management of tinnitus, with no cure existing and treatment focusing on symptom management and quality of life improvement 13
- A team approach is encouraged for optimal management, requiring familiarity with hearing aids, hearing-assistive technology, and tinnitus management strategies, particularly for patients with comorbid depression or anxiety 13
- Long-term follow-up is necessary, as some patients will have underlying causes identified only after extended observation, and 10-15% of cases of bilateral tinnitus have identifiable underlying causes 13
Coordinated Care and Follow‑Up for Chronic Tinnitus
Multidisciplinary Team Roles
- Otolaryngology should provide ongoing medical oversight and monitor for delayed‑presentation causes, which are identified in approximately 10–15 % of patients only after long‑term follow‑up. (American Academy of Otolaryngology‑Head and Neck Surgery) 14
- Audiology is responsible for fitting hearing aids, delivering sound‑therapy devices, and supplying hearing‑assistive technology for patients with any degree of hearing loss. (American Academy of Otolaryngology‑Head and Neck Surgery) 14
Long‑Term Management
- Regular follow‑up visits are essential because underlying etiologies may become apparent only after extended observation, and patients with partial or no improvement require continued audiologic and psychological support. (American Academy of Otolaryngology‑Head and Neck Surgery) 14
- Clinicians should be familiar with implantable hearing solutions (e.g., cochlear implants, bone‑anchored hearing aids) for individuals with severe hearing loss and persistent bothersome tinnitus. (American Academy of Otolaryngology‑Head and Neck Surgery) 14
Safety Screening and Diagnostic Evaluation for Tinnitus (Evidence from AAO‑HNS)
Psychiatric Risk Screening
Evidence level: observational data indicating association with suicide risk.
Otoscopic Examination Prior to Treatment
Evidence level: clinical practice guideline based on expert consensus and diagnostic studies.
Importance of Routine Psychiatric Screening (Pitfall to Avoid)
Evidence level: same observational data as above highlighting the risk.
Reassessment of Persistent Tinnitus Symptoms
Follow‑Up Recommendations
Evidence‑Based Management of Chronic Subjective Tinnitus
First‑Line Audiologic Intervention
- Hearing‑aid evaluation is recommended for any patient with documented hearing loss and persistent bothersome tinnitus, even when the loss is mild or unilateral; hearing aids provide significant relief and constitute the first‑line audiologic treatment with strong evidence of benefit. – American Academy of Otolaryngology‑Head and Neck Surgery [17]
Cognitive‑Behavioral Therapy (CBT)
- CBT is the single most effective intervention for chronic subjective tinnitus, being the only treatment demonstrated in large randomized controlled trials to improve health‑related quality of life; it is strongly recommended for all patients with persistent, bothersome tinnitus. – American Academy of Otolaryngology‑Head and Neck Surgery [17]
Education & Counseling
- All patients with persistent, bothersome tinnitus should receive education and counseling about tinnitus mechanisms, natural history, and management strategies at the initial visit; this improves patient expectations and engagement. – American Academy of Otolaryngology‑Head and Neck Surgery [17]
Sound‑Therapy (Adjunct)
- Sound therapy may be offered as an adjunctive option to provide symptomatic relief; notched sound therapy has been shown to reduce perceived tinnitus loudness more than CBT, although CBT remains superior for reducing tinnitus‑related distress. – American Academy of Otolaryngology‑Head and Neck Surgery [17]
Treatments to Avoid – Medications
- Routine use of antidepressants, anticonvulsants, anxiolytics, or intratympanic medications for primary tinnitus treatment is not recommended; systematic reviews and randomized trials demonstrate insufficient benefit and potential harms, leading to a strong recommendation against their use. – American Academy of Otolaryngology‑Head and Neck Surgery [17]
Treatments to Avoid – Dietary Supplements
- Ginkgo biloba, melatonin, zinc, and other dietary supplements should not be recommended for persistent tinnitus because evidence shows a lack of consistent efficacy and they represent unnecessary expense; this is a strong recommendation against their use. – American Academy of Otolaryngology‑Head and Neck Surgery [17]
Common Pitfalls (Guideline Highlights)
- Failure to evaluate even mild or unilateral hearing loss can miss an opportunity for beneficial hearing‑aid intervention; clinicians should ensure hearing‑aid assessment for all such patients. – American Academy of Otolaryngology‑Head and Neck Surgery [17]
Imaging and Diagnostic Recommendations for Unilateral Tinnitus
Initial Clinical Assessment
- Classify tinnitus as pulsatile versus non‑pulsatile at the first visit because the presence of a pulsatile quality directs the need for vascular imaging, while non‑pulsatile unilateral tinnitus mandates neuro‑otologic imaging. 18
Neuro‑otologic Imaging
Magnetic resonance imaging (MRI) with a dedicated internal auditory canal protocol is the preferred study to exclude vestibular schwannoma or other retro‑cochlear lesions in any patient with unilateral tinnitus. The American Academy of Otolaryngology‑Head and Neck Surgery issues a strong recommendation for this approach when tinnitus is unilateral, regardless of age or hearing status. 18
The same academy recommends against routine imaging when tinnitus is bilateral, non‑pulsatile, and lacks focal neurological deficits or asymmetric hearing loss. This conditional recommendation underscores that imaging is unnecessary only in the clearly low‑risk bilateral scenario. 18
Vascular Imaging for Pulsatile Tinnitus
- When tinnitus is pulsatile, obtain computed tomography angiography (CTA) with mixed arterial‑venous phase or magnetic resonance angiography (MRA) to identify vascular abnormalities such as dural arteriovenous fistulas, aberrant vessels, or vascular tumors. This imaging is considered essential for evaluating potentially treatable vascular causes. 18